Developing vaccines and biologics for infectious diseases
Task V29: STORAGE OF GMP AND NON-GMP MATERIALS FOR NIAID
This study is working on creating new vaccines to help protect people from serious infections, including those that could come from bioterrorism, so that patients can have better options for staying healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10490542 on NIH RePORTER |
What this research studies
This research focuses on the development and manufacturing of vaccines and biologics aimed at combating infectious diseases, including those that may arise from bioterrorism. It involves planning and feasibility assessments, as well as compliant manufacturing processes for early-phase clinical studies. The project also includes toxicology studies and regulatory support to ensure that new vaccines meet FDA standards. Patients may benefit from the introduction of new vaccines that protect against serious infectious threats.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk for infectious diseases or those involved in clinical trials for new vaccines.
Not a fit: Patients with established immunity to the targeted infectious diseases or those not at risk may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that protect patients from infectious diseases and bioterrorism threats.
How similar studies have performed: Previous research has shown success in developing vaccines for infectious diseases using similar methodologies, indicating a promising approach.
Where this research is happening
New York, United States
- International AIDS Vaccine Initiative — New York, United States (Active)
Researchers
- Principal investigator: Hassel, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassel, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.